Showing results (901-910 of 3,241) with videos related to
Sort By:
Pageof 325
Journal of Clinical Pharmacy and Therapeutics|September 7, 2020
Complete response induced by anti-PD-1-based immunotherapy with toripalimab in a patient with locally advanced lung adenocarcinoma who failed rapidly after concurrent chemoradiotherapy: A case reportWenji Xue, Tao Zhang, Xin Wang, et al.Journal of Clinical Pharmacy and Therapeutics|September 28, 2020
Evaluation of the plasma concentration of ponatinib in a chronic myeloid leukaemia patient with ponatinib intoleranceMaiko Abumiya, Naoto Takahashi, Tomoko Yoshioka, et al.Journal of Clinical Pharmacy and Therapeutics|August 30, 2020
Risk factors for tigecycline-induced hypofibrinogenaemiaQian Zhang, Jine Wang, Hui Liu, et al.Journal of Clinical Pharmacy and Therapeutics|August 30, 2020
Successful intraosseous factor VIII application in a haemophilic emergencyAtanas Banchev, Denka Stoyanova, Boryana Avramova, et al.Journal of Clinical Pharmacy and Therapeutics|September 10, 2020
Managing the multifaceted nature of type 2 diabetes using once-weekly injectable GLP-1 receptor agonist therapyAndrew BzowyckyjJournal of Clinical Pharmacy and Therapeutics|September 10, 2020
Cardiovascular safety outcomes of once-weekly GLP-1 receptor agonists in people with type 2 diabetesJennifer D GoldmanJournal of Clinical Pharmacy and Therapeutics|October 7, 2020
Pharmacist perceptions of CliftonStrengths® themes important for success in advanced cardiovascular life supportSusan E Smith, Parisa Ayers, Andrea Sikora Newsome, et al.Journal of Clinical Pharmacy and Therapeutics|January 7, 2020
The use of sodium-glucose co-transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?Theocharis Koufakis, Omar G Mustafa, Ramzi A Ajjan, et al.Journal of Clinical Pharmacy and Therapeutics|January 9, 2020
Low-dose oral propranolol for treatment of thyrotoxic periodic paralysis with hypokalaemia in the emergency department: A case reportChanie Wassner, Susan H ChengJournal of Clinical Pharmacy and Therapeutics|January 23, 2019
Tolerability of Midazolam to treat acute agitation in elderly demented patients: A systematic reviewFrédéric Bloch, Ilhem Karoui, Samir Boutalha, et al.Pageof 325